TC Medical(SH:600763) Sou Hu Cai Jing·2025-10-25 20:35Core Viewpoint - Tongce Medical (600763) shows steady growth in revenue and profit, with plans for expansion and cost optimization in the healthcare sector [1] Company Announcement Summary - As of October 24, 2025, Tongce Medical's stock closed at 42.02 yuan, up 0.17% from the previous week, with a total market capitalization of 18.795 billion yuan [1] - The company held a semi-annual performance briefing on October 22, 2025, reporting 89 medical institutions and 4,452 professional medical personnel [1] - In the first half of 2025, outpatient visits reached 1.7322 million, a year-on-year increase of 1.21% [1] - Revenue for the first half of 2025 was 1.448 billion yuan, up 2.68% year-on-year, with a net profit attributable to shareholders of 321 million yuan, reflecting a 3.67% increase [1] - The net cash flow from operating activities was 355 million yuan, a 9.7% increase year-on-year [1] - Medical service revenue in Zhejiang Province was 1.22 billion yuan, up 2.6% year-on-year [1] - The company achieved a gross margin of 40.75% and a net margin of 26.26% [1] - Orthodontics business grew by 7.75%, while pediatrics accounted for 17.6% of total revenue [1] - The Loudi Dental Hospital reported a revenue increase of 7% year-on-year [1] - The company has completed supply chain integration, leading to a continuous decline in material costs [1] - A new branch in Shanghai is expected to open by the end of 2025, with plans to establish five new branches in 2025 [1] - The company is focusing on optimizing costs by training a team of doctors and improving diagnostic efficiency due to high labor costs [1]